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Abstract
Background
Sepsis, including severe sepsis and septic shock, is a major cause of morbidity and mortal-
ity. Albumin and C-reactive protein (CRP) are considered as good diagnostic markers for
sepsis. Thus, initial CRP and albumin levels were combined to ascertain their value as an
independent predictor of 180-day mortality in patients with severe sepsis and septic shock.
Materials and Methods
We conducted a retrospective cohort study involving 670 patients (>18 years old) who were
admitted to the emergency department and who had received a standardized resuscitation
algorithm (early goal-directed therapy) for severe sepsis and septic shock, from November
2007 to February 2013, at a tertiary hospital in Seoul, Korea. The outcome measured was
180-day all-cause mortality. A multivariate Cox proportional hazard model was used to iden-
tify the independent risk factors for mortality. A receiver operating characteristic (ROC)
curve analysis was conducted to compare the predictive accuracy of the CRP/albumin ratio
at admission.
Results
The 180-day mortality was 28.35% (190/670). Based on the multivariate Cox proportional
hazard analysis, age, the CRP/albumin ratio at admission (adjusted HR 1.06, 95% CI 1.03–
1.10, p<0.001), lactate level at admission (adjusted HR 1.10, 95% CI 1.05–1.14, p<0.001),
and the Sequential Organ Failure Assessment (SOFA) score at admission (adjusted HR
1.12, 95% CI 1.07–1.18, p<0.001) were independent predictors of 180-day mortality. The
PLOSONE | DOI:10.1371/journal.pone.0132109 July 9, 2015 1 / 13
OPEN ACCESS
Citation: Kim MH, Ahn JY, Song JE, Choi H, Ann
HW, Kim JK, et al. (2015) The C-Reactive Protein/
Albumin Ratio as an Independent Predictor of
Mortality in Patients with Severe Sepsis or Septic
Shock Treated with Early Goal-Directed Therapy.
PLoS ONE 10(7): e0132109. doi:10.1371/journal.
pone.0132109
Academic Editor: Luciano Cesar Pontes Azevedo,
Hospital Sirio-Libanes, BRAZIL
Received: February 25, 2015
Accepted: June 10, 2015
Published: July 9, 2015
Copyright: © 2015 Kim et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: The authors received no specific funding
for this work.
Competing Interests: The authors have declared
that no competing interests exist.
area under the curve of CRP alone and the CRP/albumin ratio at admission for 180-day
mortality were 0.5620 (P<0.001) and 0.6211 (P<0.001), respectively.
Conclusion
The CRP/albumin ratio was an independent predictor of mortality in patients with severe
sepsis or septic shock.
Introduction
Sepsis, including severe sepsis and septic shock, remains a major cause of morbidity and mor-
tality worldwide [1]. The mortality rate of severe sepsis is 20–30% [2–4], accounting for about
30–50% of hospital deaths [5]. Even though the mortality rate of severe sepsis has decreased
markedly since the introduction of early resuscitative treatments, including early goal-directed
therapy (EGDT), survivors are still at increased risk of death [6, 7]. And reports about elderly
suggest survivors of sepsis are at increased risk of death, months and even years after hospital
discharge [8].
The inflammatory response is important in the pathophysiology of sepsis, and the impact of
inflammation that can worsen chronic illness, which is a major determinant of adverse, long-
term outcomes. Thus, biomarkers that can be used as independent prognostic factors to evalu-
ate the mortality of patients with severe sepsis or septic shock should be measured objectively
to reflect the inflammatory processes as well as responses to therapeutic intervention. As the
level of C-reactive protein (CRP) increases markedly in response to infection, and the magni-
tude of the increase may correlate with the severity of the infection [9, 10], the prognostic value
of CRP levels has been investigated in many diseases [11, 12]. Albumin is also a potent prog-
nostic marker of outcomes in infection-related disease, as its levels decrease during the
response to acute phase infections [12, 13]. Based on these properties, we speculated that the
ratio of CRP to albumin could be used as a predictive marker for mortality, as has been
observed in other diseases [14, 15]. Little is known about the prognostic accuracy of mortality
in severe sepsis or septic shock treated with EGDT. We investigated the use of the CRP/albu-
min ratio as an independent predictor of mortality in these patients where we hypothesized
that this ratio could be used as an independent predictor of mortality in patients with severe
sepsis or septic shock.
Materials and Methods
Ethics statement
The study was approved by the Institutional Review Board (IRB) of Yonsei University Health
System Clinical Trial Center. Since the study was retrospective and the study subjects were
anonymized, the IRB waived the requirement for written consent from the patients.
Study population
A retrospective cohort study was conducted, and included adult patients (>18 years) admitted
to the emergency department (ED) of Severance Hospital at Yonsei University College of Med-
icine (Seoul, Korea) with severe sepsis and/or septic shock, from November 2007 to February
2013. Severance Hospital is a 2000-bed tertiary-care teaching hospital. At this institute, EGDT
has been implemented in the intensive care unit and the ED since November 2007 as part of a
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quality improvement initiative. On average, 200 patients a day were screened, and those with
two or more systemic inflammatory response syndrome criteria, and signs of infection, were
evaluated for EGDT eligibility. One or both of the following conditions triggered initiation of
the EGDT protocol: (a) an initial systolic blood pressure of<90 mmHg despite intravenous
challenge with 20 ml/kg of crystalloid fluid or (b) an initial serum lactate level of4 mmol/L.
The exclusion criteria for this study included: (a) age<18 years, (b) any contraindication to
central venous catheterization, (c) pregnancy, (d) acute cerebrovascular accident, (e) acute cor-
onary syndrome, (f) active gastrointestinal bleeding, (g) trauma, (h) drug overdose, (i) require-
ment for immediate surgery, (j) absence of informed consent, (k) transfer to another
institution, and/or (l) a do-not-resuscitate order.
The resuscitation team was composed of an emergency medicine specialist, a physician and
an anaesthesiologist who followed the protocol outlined in the surviving sepsis campaign man-
agement guidelines [16]. The team immediately positioned a central venous catheter to moni-
tor pressure and central venous oxygen saturation (ScvO2) and to administer intravenous
fluids, vasopressors or packed red cell transfusions. The protocol in this study specified crystal-
loids as the resuscitative fluid and specified norepinephrine as the vasopressor. Patients were
resuscitated up to 6 h after enrollment and were evaluated to ascertain whether the goal was
achieved. All other aspects of care were administered at the discretion of the treating physician.
Laboratory measurements
Uniformity of data collection was achieved through implementation of the EGDT protocol
[17], which was designed based on the surviving sepsis protocol. A complete blood count
(CBC), serum albumin, and CRP and lactate levels of patients were checked at admission to the
ED as part of a routine test. ScvO2 was checked upon EGDT enrollment, and was monitored
again 2, 4, and 6 h afterwards. Serum albumin and CBC levels were monitored daily and CRP
was monitored every 3 to 4 d using an automatic nephelometer (Beckman Coulter, Fullerton,
CA, USA). Normal ranges were 0.0–0.80 mg/dL for CRP and 35.0–53.0 g/L for albumin. Other
laboratory tests, such as a CBC with a red blood cell distribution width (RDW), procalcitonin,
lactate, N-terminal pro-hormone brain natriuretic peptide (pro-BNP), and serum chemistry
were also performed within 1 h of admission.
Data collection
Medical records of all patients included were reviewed, and relevant clinical, biological and
radiological data were collected. Baseline characteristics, including demographic information
and pre-existing chronic comorbidities, were also noted. The comorbidities included diabetes,
chronic heart failure, chronic liver disease, chronic pulmonary disease, and malignancy. Initial
hemodynamic parameters, including central venous pressure, mean arterial pressure, and
ScvO2, were also collected. Disease severity was assessed by the worst scores using the acute
physiology and chronic health evaluation (APACHE) II, and the sequential organ failure
assessment (SOFA) tools, within the first 24 h of ED admission. Additional data such as, time
from enrolment to first dose of antibiotics, receipt of mechanical ventilation or whether the
patients had received renal replacement therapy, were also noted. The follow-up was evaluated
upon the patient’s death or on the last day of the outpatient visit. Mortality was assessed via the
hospital records.
Statistical analysis
Patients lost to follow-up before 180 days were regarded as non-informative censoring. We
hypothesized that there was no difference in the baseline characteristics between those who
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were censored and who were followed up to the end point. In order to explore our hypothesis
we conducted statistical analysis comparing baseline characteristics of either group. Baseline
characteristics were compared using the Mann-Whitney U test and the independent samples t-
test for the continuous variables, and the χ2 test for categorical variables. Continuous variables
were expressed as means ± standard deviation, or medians (interquartile ranges) and categori-
cal variables as numbers with percentages for the description of baseline characteristics. Sensi-
tivity, specificity, and positive and negative predictive values were calculated using standard
methods [18]. Diagnostic performance was compared by the weighted least squares method.
The Cox proportional hazards model was used to determine whether each variable was an
independent prognostic factor of mortality. The proportional-hazards assumption was tested
by the inclusion of an interaction term between all variables and the natural-log-transformed
follow-up time. It was also checked by a log-minus-log survival plot for the categorical vari-
ables. We intended to exclude variables that didn’t fit the assumption of proportionality.
Covariates for the multivariate Cox model were selected based on a p-value<0.05 in a univari-
ate analysis. Variables that could produce multicollinearity were excluded from the analysis.
To fully explore the role of the CRP/albumin ratio as a biomarker in the prediction of 180-day
mortality, the ratio was also assessed as a binary variable using the cut off value. Variables were
considered significant if p<0.05, and the results were presented as hazard ratios with 95%
confidence intervals (CIs). Prediction accuracy was assessed using the area under the receiver
operating characteristic (ROC) curve. Cut-off values showing the greatest accuracy were deter-
mined using a sensitivity/specificity versus criterion value plot. The patients were categorized
into two groups based on this cut-off value. Survival curves were created using the Kaplan-
Meier method and compared using the log-rank test. Statistical analyses were performed using
SAS version 9.2 (SAS Institute Inc., Cary, NC, USA).
Results
Population characteristics
In total, 690 patients with severe sepsis and septic shock were treated with EGDT between
November 2007 and February 2013. Among them, 11 patients were excluded due to a lack of
data, including CRP and albumin levels at admission. A further 9 patients who did not com-
plete the treatment according to the protocol due to patient refusal were also excluded; there-
fore, data from 670 patients were analyzed. In total, 167 patients were censored before the full
180 days due to loss of follow up. And 190 (28.35%) died within this period.
The mean age of the enrolled patients was 65.06 ± 14.39, and 352 (52%, 352/670) were male.
The median length of follow up of non-survivors was 18 days (0–178). The median SOFA
score of the patient was 8(6–10). More than 30% of the patients had diabetes mellitus and
more than 30% of the patients had cancer (Table 1).
The CRP/albumin ratio as an independent predictor of 180-day all-cause
mortality
In a univariate Cox proportional hazard analysis, age, gender, SOFA score, malignancy, CRP,
albumin, the CRP/albumin ratio at admission and CRP/albumin ratio at 72 h after admission
were significantly associated with 180-day mortality. Furthermore, in a multivariate Cox pro-
portional hazard analysis, age (p = 0.001), SOFA score (p<0.001), lactate level (p<0.001), and
CRP/albumin ratio (p<0.001) at admission were independent predictors of mortality. The haz-
ard ratio of 180-day mortality for severe sepsis patients with an elevated CRP/albumin ratio
was 1.06 (95% CI, 1.03–1.10), that for an elevated SOFA score was 1.12 (95% CI, 1.07–1.180),
CRP/Albumin as a Predictor of Mortality in Severe Sepsis
PLOS ONE | DOI:10.1371/journal.pone.0132109 July 9, 2015 4 / 13
Table 1. Baseline features of the enrolled patients.
Total
Characteristic
Age (years) 65.06±14.39
Male Gender 352(52.54)
Laboratory Analysis
CRP (mg/dL)1 15.22±1.12
Albumin (g/L) 31.41±7.17
CRP1/albumin ratio 5.298±4.258
CRP (mg/dL)1 at 72 h a 11.56±10.02
Albumin (g/L) at 72 h b 27.01±5.57
CRP1/albumin ratio at 72 h c 4.58±4.15
Procalcitonin (ug/L) d 35.75±53.52
WBC (x103/mm3)2 13221.47±10568.73
BUN (mg/dL)3 34.34±28.43
Cr (mg/dL)4 2.10±1.87
Lactate (mmol/L) e 4.14±3.46
Rate of goals achieved
CVP5 524/670 (78.21)
MAP6 646/670 (96.41)
ScvO2
7 574/670 (85.67)
Comorbidities
DM8 215/670(32.09)
COPD9 64/670(9.55)
CHF10 68/670(10.15)
CRF11 69/670(10.31)
Chronic liver disease 64/670(9.55)
Malignancy 233/670(37.89)
SOFA score12 8(6–10)
Time from enrollment to ﬁrst dose of antibiotics (minutes) 117.96±130.26
The data was divided into two groups according to survival status at 180 days. Data are expressed as the
mean ± SD / median (Q1-Q3) or N (%).
Abbreviations
1CRP, C-reactive protein
2WBC, white blood cell count
3BUN, blood urea nitrogen
4Cr, creatinine
5CVP, central venous pressure (Goal of CVP in EGDT protocol: 8-12mm Hg)
6MAP, mean arterial pressure(Goal of CVP in EGDT protocol: >65 and 90mm Hg) and
7SCvO2, central venous oxygen saturation(Goal of CVP in EGDT protocol: >70%)
8DM, diabetes mellitus
9 COPD, chronic obstructive pulmonary disease
10CHF, congestive heart failure
11CRF, chronic renal failure
12SOFA, sequential organ failure assessment.
a the number of patients who had available data was 524
b the number of patients who had available data was 596
c the number of patients who had available data was 496
d the number of patients who had available data was 148
e the number of patients who had available data was 663.
doi:10.1371/journal.pone.0132109.t001
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that for advanced age was 1.02(95% CI, 1.01–1.03), and the ratio for patients with elevated lac-
tate levels was 1.10 (95% CI, 1.05–1.14) (Table 2).
A second model to predict 180-day mortality was also created. This model included the
CRP/albumin ratio at 72 h after admission rather than the CRP/albumin ratio at admission.
Fifty-eight patients who died within 72 h, and 116 patients with missing biomarkers at 72 h
among those not confirmed to be dead were excluded from this analysis. In this model, age,
SOFA score and lactate level were independent predictors of 180-day mortality but the CRP/
albumin ratio at 72 h after admission was not an independent predictor (Table 3).
Table 2. Cox proportional hazards analysis for 180-daymortality (CRP/albumin ratio at admission).
Variable Univariate HR1 95% CI p-value Multivariate HR 95% CI p-value
Age (per 1-y increase) 1.02 1.01–1.03 0.006 1.02 1.01–1.03 0.001
Gender
Male 1
Female 0.64 0.48–0.86 0.003 0.90 0.66–1.22 0.48
SOFA score 1.00 1.000–1.003 <0.001 1.12 1.07–1.180 <0.001
CRP at admission 1.002 1.001–1.004 0.01
Albumin at admission 0.90 0.88–0.92 <0.001
CRP/albumin at admission 1.04 1.00–1.08 <0.001 1.06 1.03–1.10 <0.001
Lactate at admission 1.14 1.11–1.18 <0.001 1.10 1.05–1.14 <0.001
Malignancy 1.76 1.31–2.36 0.001 1.24 0.79–1.95 0.344
1The hazard ratio (HR) for death is expressed per 1-y increase in age, female to male in gender, per 1 unit increase in the SOFA score, 1 mg/L increase in
CRP, 1 g/dL decrease in albumin, 1 increase in CRP (mg/dL)/albumin(g/dL), 1 mmol/dL increase in lactate and having malignancy to having no
malignancy.
The multivariate analysis was adjusted for covariates such as age, gender, CRP/albumin ratio, SOFA score, lactate level and having malignancy or not,
for each variable. Abbreviations: SOFA, sequential organ failure assessment; CRP, C-reactive protein
doi:10.1371/journal.pone.0132109.t002
Table 3. Cox proportional hazards analysis for 180-daymortality (CRP/albumin ratio at 72 h after admission).
Variable Univariate HR1 95% CI p-value Multivariate HR 95% CI p-value
Age (per 1-y increase) 1.02 1.01–1.03 0.006 1.02 1.00–1.03 0.020
Gender
Male 1
Female 0.64 0.48–0.86 0.003 0.70 0.48–1.03 0.067
SOFA score 1.197 1.15–1.25 <0.001 1.12 1.06–1.19 0.001
CRP at 72 h 1.00 1.00–1.003 0.176
Albumin at 72 h 0.86 0.83–0.9 <0.001
CRP/albumin at 72 h 1.08 1.05–1.11 <0.001 1.02 0.98–1.06 0.348
Lactate at admission 1.14 1.11–1.18 <0.001 1.06 1.01–1.12 0.027
Malignancy 1.76 1.31–2.36 0.001 1.19 0.71–2.00 0.512
1The hazard ratio (HR) for death is expressed per 1-y increase in age, female to male in gender, per 1 score increase in the SOFA score, 1 mg/L increase
in CRP, 1 g/L decrease in albumin, 1 increase in CRP(mg/dL)/albumin(g/L), 1 mmol/dL increase in lactate and having malignancy to having no
malignancy.
The multivariate analysis was adjusted for covariates such as age, gender, CRP/albumin ratio, SOFA score, lactate level and having malignancy or not,
for each variable. Abbreviation: SOFA, sequential organ failure assessment; CRP, C-reactive protein.
doi:10.1371/journal.pone.0132109.t003
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Diagnostic performance of the CRP/albumin ratio
The prediction of mortality was assessed using the area under the ROC curve (AUC) (Fig 1).
The AUC for the CRP/albumin ratio at admission (0.62 [95% CI, 0.56–0.68; p<0.001]) was
greater than that for CRP alone (0.56 [95% CI, 0.51–0.62; p<0.001]). Moreover, a mountain
curve analysis determined the most sensitive and specific cut-off value for CRP to be 6.75
mg/dL; the cut-off for the CRP/albumin ratio was 5.09 (S1 Fig). In addition, the sensitivity and
Fig 1. Receiver operating characteristic (ROC) curve of CRP and CRP/albumin ratio in predicting
180-daymortality. The area under curve (AUC) for the CRP/albumin ratio is higher compared to CRP alone
(p<0.001).
doi:10.1371/journal.pone.0132109.g001
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specificity of the CRP/albumin ratio cut-off value (>5.09) were 61 and 61%, respectively, while
the CRP cut-off value was less specific (sensitivity and specificity of 84 and 31%, respectively)
(Table 4). Analysis using the CRP/albumin ratio as the binary variable resulted in a hazard
ratio of 180-day mortality with an elevated CRP/albumin ratio of 1.74 (95% CI, 1.27–2.37) (S1
Table). A Kaplan-Meier curve analysis also showed a significantly higher 180-day mortality
rate in patients with a CRP/albumin ratio>5.09, compared to patients with a lower CRP/albu-
min ratio (Fig 2).
Discussion
With the success of initial resuscitation treatments and decreasing death rates for severe sepsis
or septic shock, the focus has moved to the later prognosis of the patients. Our study shows
that the CRP/albumin ratio at admission can be used as an independent predictor of 180-day
mortality in patients with severe sepsis or septic shock. To our knowledge, few studies have
evaluated the prognostic significance of the CRP/albumin ratio in patients treated with EGDT,
whereas many studies have investigated the use of inflammatory markers, such as CRP, procal-
citonin, and pro-BNP to predict mortality in critically ill patients [13, 19, 20]. Among these
markers, CRP is readily accessible in the critical care setting, and its value as a prognostic
marker is proven in many diseases, including cerebral disease, heart failure, and sepsis [11, 12,
21]. However, these studies mainly focused on 28- to 30-day mortality. In our study, the
end point was 180-day mortality and the significance of CRP was evaluated as a prognostic
factor in severe sepsis and septic shock patients. A high level of CRP correlated with 180-day
mortality, but with an only modest to low predictive capability. Despite previous studies that
investigated the relevance of CRP in cases of poor prognosis, its predictive value has not been
confirmed. Thiem et al. [22] reported that for hospitalized patients with community-acquired
pneumonia, the initial CRP level did not predict mortality. In another large prospective study
of nonsurgical intensive care patients, plasma CRP measured at the day of discharge from
intensive care did not predict re-admission or death [23].
Albumin levels are associated with the chronic nature of disease, and represent the inflam-
matory status [24, 25]. The value of albumin levels in predicting outcomes in chronic and
inflammatory disease is also well known [12, 13, 26]. In patients with community-acquired
bloodstream infections, with severe sepsis or septic shock, hypoalbuminemia is the strongest
predictor of mortality [13]. However, in the context of this study, hypoalbuminemia is likely to
be the result of infection rather than previous illness. As such, when evaluating patients with
Table 4. Comparison of the diagnostic performance of each factor in predicting 180-daymortality.
Day 180 TN FN FP TP Cut-off
point
Sensitivity Speciﬁcity Accuracy PPV NPV
CRP at admission 147 28 328 157 >67.5 84.86(79.70–
90.03)
30.95(26.79–
35.10)
46.06(42.26–
49.86)
32.37(28.21–
36.53)
84.00(78.56–
89.43)
CRP/Albumin at
admission
290 72 185 113 >5.09 61.08(54.06–
68.11)
61.05(56.67–
65.44)
61.06(57.34–
64.78)
37.92(32.41–
43.43)
80.11(76.00–
84.22)
CRP at 72 h 130 29 263 99 >47.13 77.34(70.09–
84.60)
33.08(28.43–
37.73)
43.95(39.69–
48.22)
27.34(22.76–
31.94)
81.76(75.76–
87.76)
CRP/Albumin at 72 h 84 15 285 112 >0.91 88.19(82.58–
93.80)
22.76(18.49–
27.04)
39.51(35.21–
43.82)
28.21(23.78–
32.63)
84.85(77.79–
91.91)
Figures in brackets indicate the 95% conﬁdence intervals of each value. Figures in TN, FN, FP, and TP indicate the numbers of patients included in each
group. Abbreviations: CRP, C-reactive protein; TN, true negative; FN, false negative; FP, false positive; TP, true positive; PPV, positive predictive value;
NPV, negative predictive value.
doi:10.1371/journal.pone.0132109.t004
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varying underlying conditions, this marker alone can create bias because albumin levels are
affected by both the chronic nutritional and inflammatory status.
It is generally believed that the worsening of a chronic illness with an ongoing infection rep-
resents a major determinant of an adverse long-term outcome in severe sepsis and septic shock
patients. Thus, rather than an analysis of each single factor on its own, CRP and albumin were
combined. The combination of these markers, enabled inflammatory and nutritional factors to
be merged, both of which strongly influence prognosis [14]. Furthermore, the CRP/albumin
ratio may be an indicator of a stronger inflammation response. In this study, the CRP/albumin
ratio at admission was positively correlated with the prognosis in severe sepsis and septic shock
patients treated with EGDT. Ranzani et al. [15] had already demonstrated that the CRP/albu-
min ratio, which indicates the extent of residual inflammation, could be used as a prognostic
Fig 2. Kaplan-Meier analysis of the cumulative percentage of surviving patients at 180-days according to the different CRP/albumin levels. Patients
with higher levels of CRP/albumin ratio had a reduced survival rate. Solid line, CRP/albumin ratio5.09; dashed line, CRP/albumin ratio >5.09.
doi:10.1371/journal.pone.0132109.g002
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marker of 90-day mortality after discharge in sepsis patients. However, in that study only 33%
of the patients had severe sepsis and septic shock, and only those patients who were discharged
alive were included. In contrast, this study included more-severe patients, of which 18% (124/
670) died before they could be discharged. Our findings showed that the CRP/albumin ratio
was able to predict prognosis even in this smaller group of patients. A CRP/albumin ratio
>5.09 had the best sensitivity and specificity in predicting 180-day mortality. There was a dif-
ference between non survivors and the rest in the proportion of patients in terms of malignancy
and age, but even after adjusting for these factors, the CRP/albumin ratio still influenced prog-
nosis at a significant level. Although the AUC for the CRP/albumin ratio was only 0.62 (95%
CI, 0.56–0.68), indicating a modest predictive capability, the survival difference depicted in the
Kaplan-Meier curve analysis supported the usefulness of this model. Our results showed that
the CRP/albumin ratio before treatment was a predictor of prognosis. The importance of the
pretreatment values was also observed in other studies that showed that initial clinical mea-
surements were often the best predictors of physiological perturbations. Specific prognostic
capabilities have been shown for a number of biomarkers, including lactate, heart rate, and
autonomic dysfunction [27–29]. Taken together with these markers, the CRP/albumin ratio at
admission can be used to stratify patients according to the severity of disease, even after the
patients have been discharged from hospital.
In this study, patients were treated with EGDT. The goal achievement rate of all three
parameters (CVP 8-12mm Hg, MAP>65 and90mm Hg, ScvO270%) was 73.45%. In this
study, we evaluated whether changes in CRP, albumin, or the CRP/albumin ratio after 72 h
would affect the patient prognosis after the resuscitative procedure; only 496 patients with
available data at 72 h were included. No statistical significance was observed for the CRP/albu-
min ratio at 72 h in patient prognosis. Our results may have been affected by the fact that the
more critically ill patients who died within 72 h were excluded from the analysis. However,
considering that the CRP/albumin ratios were still high for both groups, the result may be
interpreted as follows: Because the plasma half-life of CRP is ~19 h when the entire stimulus
for increased production completely ceases [30] while albumin levels remain constant during
that short time period of time, the CRP/albumin ratio at 72 h may have been mainly affected
by the CRP value. This value may represent residual inflammation immediately after resuscita-
tion. However, as the value at 72 h was not significant, this demonstrated that the CRP/albu-
min ratio at 72 h may not be used as a tool to guide decisions on the treatment of patients with
severe sepsis and septic shock. This is consistent with the result of a previous study of CRP val-
ues, which showed that at 2 d after treatment, the values were not significantly different
between survivors and non-survivors [31].
Well-established biomarkers, including lactate levels and SOFA scores, were used as inde-
pendent predictors in our analyses. These scores are strongly associated with organ dysfunc-
tion, and are frequently used to guide therapeutic decisions and allocate resources [32, 33]. The
contribution of changes in each of these values to the prognosis of severe sepsis and septic
shock patients should be evaluated on a larger scale.
There were several limitations to our study. First, as this was a retrospective study, possible
bias was likely. Second, the variables were collected from a single center, making generalization
of these results to other institutions difficult. Additional prospective studies with larger popula-
tions involving multiple centers are necessary to accurately evaluate the CRP/albumin ratio as
a predictor of mortality.
In conclusion, the CRP/albumin ratio is an independent predictor of long-term mortality in
patients with severe sepsis or septic shock.
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Supporting Information
S1 Fig. Plot versus criterion value curves for the CRP versus 180-day mortality and the
CRP/albumin ratio versus 180-day mortality. The X-axis shows the CRP level in mg/L and
CRP/albumin ratio. The Y-axis shows the percentage. The solid and dashed lines indicate sen-
sitivity and specificity with 95% confidence intervals, respectively.
(TIF)
S1 Table. Cox proportional hazards analysis for 180-day mortality (CRP/albumin ratio at
admission as a categorical variable).
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